Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US ... - Sacramento Bee

Vyvanse® (lisdexamfetamine dimesylate) Capsules, (CII) Now Approved in the US ... Sacramento Bee Clinical evaluation for bipolar disorder is recommended prior to stimulant use. Monitor for aggressive behavior. Monitor growth in children during treatment with Vyvanse. Children who are not growing (gaining height or weight) as expected may need to ... and more »

Henderson Sheriff's case highlights complex, sometimes devastating bipolar ... - Asheville Citizen-Times

Henderson Sheriff's case highlights complex, sometimes devastating bipolar ... Asheville Citizen-Times Professionals who deal with bipolar disorder regularly say the public needs better information to understand the complicated, often-devastating illness that affects 1-2 percent of the adult population, and up to 4 percent of the population if the ... and more »